Lymphocyte sensitisation in nifedipine-induced hepatitis

Heschi H. Rotmensch, Arie Roth, Meir Liron, Ardon Rubinstein, Alexander Gefel

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Nifedipine (Adalat) is a new, highly effective agent in the treatment of angina, with beneficial haemodynamic responses.Adverse side effects include gastrointestinal symptoms, sensation of heat, and facial flushing. We report on a patient who developed hepatitis after administration of nifedipine. The clinical course, immunological findings, and a positive challenge test result strongly indicated a hypersensitivity response.

Original languageEnglish
Pages (from-to)976-977
Number of pages2
JournalThe BMJ
Volume281
Issue number6246
DOIs
StatePublished - Oct 1980

Fingerprint

Dive into the research topics of 'Lymphocyte sensitisation in nifedipine-induced hepatitis'. Together they form a unique fingerprint.

Cite this